Key facts
- Zoetis is launching new pet therapeutics in Japan, according to Nikkei Asia.
- The report says the Japanese market for cancer and chronic illness treatments for pets is growing.
- Longer lifespans of cats and dogs are driving more spending on medicines and treatments, the report says.
Zoetis is launching new therapeutics for pets in Japan, Nikkei Asia reported on November 12, 2026, citing a growing market there for cancer and chronic illness treatments as household animals live longer lives.
The report said the lifespans of cats and dogs are growing longer, leading to more spending on medicines and treatments. It named no specific products, launch dates, prices or sales targets, and gave no figure for the size of the Japanese pet medicines market.
The item appeared in a Nikkei Asia pharmaceuticals section that also carried unrelated reports on Towa Pharmaceutical, Takeda and other companies. Those items are not covered here.